Companies: 49,247 Total Market Cap: 132739962408346.71

Zhejiang East Asia Pharmaceutical

SHA-605177
Healthcare Pharmaceuticals
Rank #17709
Market Cap 276.00 M
Volume 1.12 M
Price 2.49
Change (%) 1.36%
Country or region China China

Zhejiang East Asia Pharmaceutical's latest marketcap:

276.00 M

As of 05/21/2025, Zhejiang East Asia Pharmaceutical's market capitalization has reached $276.00 M. According to our data, Zhejiang East Asia Pharmaceutical is the 17709th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 276.00 M
Revenue (ttm) 143.67 M
Net Income (ttm) -18,242,369.01
Shares Out 112.57 M
EPS (ttm) -0.16
Forward PE 8.00
Ex-Dividend Date 07/04/2024
Earnings Date 04/30/2025
Market Cap Chart
Data Updated: 05/21/2025

Zhejiang East Asia Pharmaceutical's yearly market capitalization.

Zhejiang East Asia Pharmaceutical has seen its market value drop from ¥4.03 B to ¥1.99 B since 2020, representing a total decrease of 50.62% and an annual compound decline rate (CAGR) of 14.86%.
Date Market Cap Change (%)
05/21/2025 ¥1.99 B -12.19%
12/31/2024 ¥2.22 B -26.27%
12/29/2023 ¥3.01 B 32.27%
12/30/2022 ¥2.27 B -27.57%
12/31/2021 ¥3.14 B -22.14%
12/31/2020 ¥4.03 B

Company Profile

About Zhejiang East Asia Pharmaceutical Co., Ltd.

Zhejiang East Asia Pharmaceutical Co., Ltd. is a pharmaceutical company specializing in the production and sale of a diverse range of medical products. Established in 1992 and headquartered in Taizhou, China, the company serves both domestic and international markets.

Product Portfolio

  • Pharmaceutical Chemicals & Intermediates
  • Dosage Forms: Tablets, Granules, Capsules
  • Therapeutic Categories:
    • Quinolones Synthetic Antibacterial Agents
    • Antifungal Products
    • Gastrointestinal Medications
    • Semi-Synthetic Cephalosporin Antibiotics
    • Carbapenem Antibiotics
    • Antiviral Agents
    • Central Nervous System Medications
    • Respiratory Drugs
    • Antiallergic Agents
    • Antineoplastic Agents & Tumor Adjuvant Drugs

Key Therapeutic Fields

  • Cardiovascular
  • Anti-Aging Dementia
  • Digestive System
  • Diabetic Neuropathy
  • Anti-Pathogenic Microorganisms

Global Reach

The company operates a robust sales network, serving customers across:

  • China
  • Europe
  • United States
  • Southeast Asia
  • Other International Markets
Frequently Asked Questions

As of 05/21/2025, Zhejiang East Asia Pharmaceutical (including the parent company, if applicable) has an estimated market capitalization of $276.00 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Zhejiang East Asia Pharmaceutical global market capitalization ranking is approximately 17709 as of 05/21/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region China
Founded 1992
IPO Date n/a
Employees 1,749
CEO Cheng Chi
Sector Healthcare
Industry Pharmaceuticals
Address Chamber of Commerce Building
Taizhou, 318020
China
Website https://www.eapharm.cn/
People Also Watch
Kexing Biopharm
5.78 1.36%
PSX-GLAXO
1.32 1.36%
PSX-ABOT
3.39 1.36%
SHA-688189
0.89 1.36%